Description
This program will update HCPs on the management of T2DM with long-acting basal analogues and therapeutic intensification with combinations of basal insulin and GLP-1 RA.

This program will update HCPs on the management of T2DM with long-acting basal analogues and therapeutic intensification with combinations of basal insulin and GLP-1 RA.